About heather

This author has not yet filled in any details.
So far heather has created 695 blog entries.

APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences

STONY BROOK, N.Y. – July 18, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”), a leader in PCR-based DNA technologies, today announced the participation of LineaRx, Inc., its majority-owned biotherapeutics subsidiary, in upcoming mRNA industry conferences in Boston: July 26 – 28, the mRNA-Based Therapeutics Summit at the Boston Convention and Exhibition [...]

APDN Acquires Spindle Biotech, Launches LineaIVT Platform

Jul 13, 2023 | staff reporter Save for later NEW YORK – Applied DNA Sciences announced on Thursday that it acquired RNA polymerase developer Spindle Biotech. The acquisition enables Applied DNA to combine its LinearDNA IVT platform with Spindle's proprietary, high-performance RNA polymerase (RNAP) into an integrated platform called LineaIVT, for which Applied DNA also [...]

2023-07-14T09:39:23-04:00Categories: APDN in the News, Linear DNA|Tags: , , |

APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform

STONY BROOK, N.Y. – July 13, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that it has acquired Spindle Biotech Inc. (“Spindle”), an early-stage, private biotech company developing next-generation RNA manufacturing technologies. The acquisition uniquely leverages the Company’s LinearDNA™ [...]

White Paper: Next Gen Medicines, The Therapeutic Potential of linearDNA Delivered via Lipid Nanoparticle

A novel approach of using a DNA therapeutic platform with a Lipid Nanoparticle (LNP)-based delivery system and focused on veterinary vaccine applications has been evaluated and our preliminary results are reported in this white paper. The studies shown herein support the advancement of high-fidelity, PCR-produced linearDNA™ in vaccine applications, taking advantage of [...]

2023-06-15T07:32:14-04:00Categories: APDN in the News, Linear DNA|

How are dupes different than fakes? Lineapple Magazine breaks it down

By Applied DNA Sciences | June 1, 2023 A new article titled “They Are Not Fakes, They Are Dupes: They Appeal to Those Who Say They Are Green” sheds light on a growing concern in the world of brand protection and authenticity. The growing popularity of “dupes” or [...]

APDN in The NY Times: Revolutionizing Supply Chains with DNA Technology

By Applied DNA Sciences | May 15, 2023 Applied DNA has been featured on the front page of the New York Times, in a recent article titled “AI Technology Meets DNA to Transform Supply Chains.” The article explores how Applied DNA’s groundbreaking advancements are revolutionizing supply chain management by combining [...]

Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update

STONY BROOK, N.Y. - May 11, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the second quarter of fiscal 2023 ended March 31, 2023. Commenting on the Company’s quarterly performance, Dr. James A. Hayward, president and [...]

2023-05-12T11:17:10-04:00Categories: Press Release|Tags: |

APDN to Report FQ2’23 Financial Results; Investor Conference Call/Webcast 5/11

STONY BROOK, N.Y. – May 3, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company [...]

2023-08-07T11:27:36-04:00Categories: Press Release|Tags: , |
Go to Top